SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-043130
Filing Date
2010-05-04
Accepted
2010-05-04 07:00:15
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b80515e10vq.htm 10-Q 326946
2 EX-10.1 b80515exv10w1.htm EX-10.1 50276
3 EX-10.2 b80515exv10w2.htm EX-10.2 23999
4 EX-10.3 b80515exv10w3.htm EX-10.3 60175
5 EX-31.1 b80515exv31w1.htm EX-31.1 6801
6 EX-31.2 b80515exv31w2.htm EX-31.2 6818
7 EX-32.1 b80515exv32w1.htm EX-32.1 4026
8 EX-32.2 b80515exv32w2.htm EX-32.2 4047
  Complete submission text file 0000950123-10-043130.txt   484580
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 10794925
SIC: 2836 Biological Products, (No Diagnostic Substances)